Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice.
about
Mouse models to study the effect of cardiovascular risk factors on brain structure and cognitionCerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel diseaseIntact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazoneNeuroimaging Biomarkers Predict Brain Structural Connectivity Change in a Mouse Model of Vascular Cognitive Impairment.Chronic neurological deficits in mice after perinatal hypoxia and ischemia correlate with hemispheric tissue loss and white matter injury detected by MRIStress-induced glucocorticoid receptor activation determines functional recovery following ischemic stroke.Cardiotonic pill attenuates white matter and hippocampal damage via inhibiting microglial activation and downregulating ERK and p38 MAPK signaling in chronic cerebral hypoperfused rat.White matter injury due to experimental chronic cerebral hypoperfusion is associated with C5 deposition.Neurovascular function in Alzheimer's disease patients and experimental models.L-carnitine enhances axonal plasticity and improves white-matter lesions after chronic hypoperfusion in rat brainVascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairmentBrain volume and neurobehavior in newborns with complex congenital heart defects.Salvia miltiorrhiza extract protects white matter and the hippocampus from damage induced by chronic cerebral hypoperfusion in ratsThe Role of Autophagy in the Correlation Between Neuron Damage and Cognitive Impairment in Rat Chronic Cerebral Hypoperfusion.Micro-heterogeneity of flow in a mouse model of chronic cerebral hypoperfusion revealed by longitudinal Doppler optical coherence tomography and angiography.Microvascular damage is involved in the pathogenesis of heroin induced spongiform leukoencephalopathy.Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementiaVascular cognitive impairment and Alzheimer's disease: role of cerebral hypoperfusion and oxidative stress.CX3CR1 RNAi inhibits hypoxia-induced microglia activation via p38MAPK/PKC pathway.Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changesDimethyl fumarate improves white matter function following severe hypoperfusion: Involvement of microglia/macrophages and inflammatory mediators.Necrostatin-1 Attenuates Inflammatory Response and Improves Cognitive Function in Chronic Ischemic Stroke Mice.Alterations of Caspr2 and Nav1.6 on myelinated axon damage in a rat model of chronic cerebral hypoperfusion.Adrenomedullin deficiency and aging exacerbate ischemic white matter injury after prolonged cerebral hypoperfusion in mice.Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway.Selective in vivo antagonism of endothelin receptors in transforming growth factor-beta1 transgenic mice that mimic the vascular pathology of Alzheimer's disease.Gradual Cerebral Hypoperfusion Impairs Fear Conditioning and Object Recognition Learning and Memory in Mice: Potential Roles of Neurodegeneration and Cholinergic Dysfunction.Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation confers functional neuroprotection in global ischemia.Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse Hippocampus.New GABAergic Neurogenesis in the Hippocampal CA1 Region of a Gerbil Model of Long-Term Survival after Transient Cerebral Ischemic Injury.Bilateral carotid artery stenosis causes unexpected early changes in brain extracellular matrix and blood-brain barrier integrity in mice.Ambiguous Effects of Autophagy Activation Following Hypoperfusion/Ischemia
P2860
Q30427103-20E79B6A-F7A4-42F8-B180-A08A130956DDQ30492865-E30261A7-BF65-4ED9-A046-6AE3CCAA4912Q30498345-8125EAAB-C11A-4E0B-9DB8-778DB21D4B54Q31153789-6AA0E336-1041-4963-82DB-5DF905D85167Q33941926-667EA413-2081-4403-8935-8BDC8A6ACC25Q34198946-2EF268DE-BCC3-4828-8FEC-BF073749C4BDQ34465031-605AA750-639B-41FF-8ECA-CAA7A560A5A3Q35081055-6CFCB9D8-59E2-463D-B4FD-097DA1F6F25EQ35088223-BD990DE0-8EB2-441D-A0A9-3812BE295C45Q35143473-3DA794CD-8A85-4B73-B810-78E153A6F5C0Q35143520-06D9EDA1-E857-48C7-9312-BB8CCDFC0BA5Q35760297-AB4050CA-28C2-4373-9EA1-0D67B6871F2EQ35849340-1A895273-9CE1-4121-AA8C-D7A632D76EAEQ36241698-395651F2-CD80-4C81-A972-59271A689447Q36267422-E63CF2A1-71A4-40CE-BA22-975D0AA024C2Q36619201-542036FE-FC87-45FE-B88E-371C65B6D57AQ37150886-D64738B7-2ED9-4FB5-888C-01F1303E1131Q38032754-F39B5C92-BDE1-4678-B1DD-A666635146C0Q39015586-57ADE06B-DF6C-43CD-9913-A232BE8AECF6Q39114617-A0CBC032-49E0-4DC6-89CE-F12CB9CA9963Q40163126-DC1BD6A2-7667-4CB4-8D08-2425E3E8CF61Q41747860-0F7EA854-CCA9-4CE0-883D-27E9BCAC549AQ41861637-A43AA197-047E-41D5-B737-3CCB6A41DBC6Q42181196-95D90AF0-890F-4ADE-9AFA-4AF4A6C85CD0Q42546704-88EE2521-3F64-41AE-91A8-1ADA23CD73B9Q42971227-A7EBB69F-3257-4033-BDD4-0B985D701FBAQ47445956-3FCDDE0D-5CF3-4D0E-BF7A-0F3F51B54BB0Q48176203-298F8165-B754-44DD-8B0F-8D5A9672FC7FQ48656776-625FCA8B-DAC9-4C11-9403-AAE79E8A14E2Q50552616-27FB6BE1-F577-4DDA-B686-6817F0FD3642Q52591809-2F704192-2106-44CC-9BE3-C1CE343E03C6Q58742621-BE62BC99-2C4C-4535-A58E-7B5C5FBCB3CD
P2860
Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Intensity of chronic cerebral ...... ive/motor dysfunction in mice.
@ast
Intensity of chronic cerebral ...... ive/motor dysfunction in mice.
@en
type
label
Intensity of chronic cerebral ...... ive/motor dysfunction in mice.
@ast
Intensity of chronic cerebral ...... ive/motor dysfunction in mice.
@en
prefLabel
Intensity of chronic cerebral ...... ive/motor dysfunction in mice.
@ast
Intensity of chronic cerebral ...... ive/motor dysfunction in mice.
@en
P2093
P2860
P356
P1476
Intensity of chronic cerebral ...... ive/motor dysfunction in mice.
@en
P2093
Hidehiro Mizusawa
Kazunori Miki
Liyuan Sun
Satoru Ishibashi
Toshihiko Kuroiwa
Wataru Ohashi
P2860
P304
P356
10.1002/JNR.21925
P577
2009-04-01T00:00:00Z